Medications for Controlling Excessive Sweating
For excessive sweating (hyperhidrosis), start with topical aluminum chloride hexahydrate, then escalate to oral anticholinergics (oxybutynin or glycopyrronium), followed by botulinum toxin injections if needed.
First-Line Treatment: Topical Agents
Begin with topical aluminum chloride hexahydrate applied to affected areas 1, 2. This is the least invasive option with minimal systemic effects. Apply at night to dry skin and wash off in the morning.
Second-Line Treatment: Oral Anticholinergics
When topical therapy fails, oral anticholinergic medications are the next step:
Oxybutynin (Most Evidence)
- Dosing: Start 5-10 mg daily
- Efficacy: Improves symptoms in 76.2% of patients (range 60-97%) and quality of life in 75.6% 3, 2
- Side effects: Dry mouth occurs in 73.4% at 10 mg/day 3
- Key advantage: Most studied anticholinergic for hyperhidrosis 4, 5
Glycopyrronium (Alternative)
- Topical forms: Glycopyrronium bromide or tosylate 1, 2
- Oral form: Available but less studied
- Side effects: Dry mouth in 38.6% (lower than oxybutynin) 3
Methantheline Bromide
Important caveat: Approximately 10.9% of patients discontinue anticholinergics due to adverse effects, primarily dry mouth 3. Other anticholinergic effects include mydriasis, urinary retention, and headache 6.
Third-Line Treatment: Botulinum Toxin
For focal hyperhidrosis (especially axillary) not responding to oral therapy:
- Botulinum toxin injections provide marked improvement in 60-70% of patients 6, 5
- Highly effective for localized areas 2
- Side effects: Local pain, cutaneous irritation 6
Additional Options
For Palmar/Plantar Hyperhidrosis
Newer Topical Agents
Treatment Algorithm
- Mild disease: Topical aluminum chloride
- Moderate disease: Add oral oxybutynin 5-10 mg daily
- Severe focal disease: Botulinum toxin injections
- Refractory cases: Consider combination therapy or procedural interventions (microwave devices, radiofrequency, surgical options) 1, 6, 2
Critical Pitfalls to Avoid
- Don't use anticholinergics as monotherapy in severe focal disease - botulinum toxin is more effective 2
- Monitor for anticholinergic burden - especially in elderly patients or those on multiple medications
- Warn patients about dry mouth - occurs in majority of patients on oral therapy; approximately 11% will stop treatment due to this 3
- Assess for secondary causes - rule out underlying conditions (thyroid disease, medications, infections) before treating as primary hyperhidrosis 6
The most practical approach: Start oxybutynin 5 mg daily, titrate to 10 mg if tolerated, and reserve botulinum toxin for focal areas that don't respond or when systemic side effects are intolerable 3, 5, 2.